Association of genetic variants in the two isoforms of 5α-reductase, SRD5A1 and SRD5A2, in lean patients with polycystic ovary syndrome

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 157, Issue 2, 2011, Pages 175-179

  Graupp, M ^a   Wehr, E ^a   Schweighofer, N ^a   Pieber, T R ^a   Obermayer Pietsch, B ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

5 Reductase; Hyperandrogenemia; Polycystic ovary syndrome; Polymorphisms

Indexed keywords

ISOENZYME; STEROID 5ALPHA REDUCTASE 1; STEROID 5ALPHA REDUCTASE 2;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HIRSUTISM; HUMAN; LEAN BODY WEIGHT; MAJOR CLINICAL STUDY; OBESITY; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 79960699088     PISSN: 03012115     EISSN: 18727654     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2011.03.026     Document Type: Article

References (32)

1. E.S. Knochenhauer, T.J. Key, M. Kahsar-Miller, W. Waggoner, L.R. Boots, and R. Azziz Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study J Clin Endocrinol Metab 83 9 1998 3078 3082 (Pubitemid 28500937)
2. E. Diamanti-Kandarakis, C.R. Kouli, and A.T. Bergiele A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile J Clin Endocrinol Metab 84 11 1999 4006 4011 (Pubitemid 30644187)
3. K.F. Michelmore, A.H. Balen, D.B. Dunger, and M.P. Vessey Polycystic ovaries and associated clinical and biochemical features in young women Clin Endocrinol (Oxf) 51 6 1999 779 786 (Pubitemid 30050829)
4. M. Asuncion, R.M. Calvo, J.L. San Millan, J. Sancho, S. Avila, and H.F. Escobar-Morreale A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain J Clin Endocrinol Metab 85 7 2000 2434 2438 (Pubitemid 32269197)
5. R. Azziz, K.S. Woods, R. Reyna, T.J. Key, E.S. Knochenhauer, and B.O. Yildiz The prevalence and features of the polycystic ovary syndrome in an unselected population J Clin Endocrinol Metab 89 6 2004 2745 2749 (Pubitemid 38766360)
6. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome Fertil Steril 81 1 2004 19 25
7. S. Jahanfar, and J.A. Eden Genetic and non-genetic theories on the etiology of polycystic ovary syndrome Gynecol Endocrinol 10 5 1996 357 364 (Pubitemid 26364676)
8. E. Diamanti-Kandarakis, and C. Piperi Genetics of polycystic ovary syndrome: searching for the way out of the labyrinth Hum Reprod Update 11 6 2005 631 643 (Pubitemid 41631312)
9. E. Fratantonio, E. Vicari, C. Pafumi, and A.E. Calogero Genetics of polycystic ovarian syndrome Reprod Biomed Online 10 6 2005 713 720 (Pubitemid 40796936)
10. R. Azziz Androgen excess is the key element in polycystic ovary syndrome Fertil Steril 80 2 2003 252 254 (Pubitemid 36959774)
11. W. Futterweit, and L. Deligdisch Histopathological effects of exogenously administered testosterone in 19 female to male transsexuals J Clin Endocrinol Metab 62 1 1986 16 21 (Pubitemid 16186837)
12. S. Jonard, Y. Robert, C. Cortet-Rudelli, P. Pigny, C. Decanter, and D. Dewailly Ultrasound examination of polycystic ovaries: is it worth counting the follicles? Hum Reprod 18 3 2003 598 603 (Pubitemid 36329332)
13. N.E. Allen, M.S. Forrest, and T.J. Key The association between polymorphisms in the CYP17 and 5alpha-reductase (SRD5A2) genes and serum androgen concentrations in men Cancer Epidemiol Biomarkers Prev 10 3 2001 185 189 (Pubitemid 34288528)
14. A.W. Hsing, C. Chen, and A.P. Chokkalingam Polymorphic markers in the SRD5A2 gene and prostate cancer risk: a population-based case-control study Cancer Epidemiol Biomarkers Prev 10 10 2001 1077 1082 (Pubitemid 32959155)
15. N.M. Makridakis, E. Di Salle, and J.K. Reichardt Biochemical and pharmacogenetic dissection of human steroid 5 alpha-reductase type II Pharmacogenetics 10 5 2000 407 413 (Pubitemid 30433574)
16. R. Andrew, D.I. Phillips, and B.R. Walker Obesity and gender influence cortisol secretion and metabolism in man J Clin Endocrinol Metab 83 5 1998 1806 1809 (Pubitemid 28501063)
17. A.J. Jakimiuk, S.R. Weitsman, and D.A. Magoffin 5alpha-Reductase activity in women with polycystic ovary syndrome J Clin Endocrinol Metab 84 7 1999 2414 2418
18. M. Fassnacht, N. Schlenz, S.B. Schneider, S.A. Wudy, B. Allolio, and W. Arlt Beyond adrenal and ovarian androgen generation: Increased peripheral 5 alpha-reductase activity in women with polycystic ovary syndrome J Clin Endocrinol Metab 88 6 2003 2760 2766 (Pubitemid 36724453)
19. T. Tsilchorozidou, J.W. Honour, and G.S. Conway Altered cortisol metabolism in polycystic ovary syndrome: insulin enhances 5alpha-reduction but not the elevated adrenal steroid production rates J Clin Endocrinol Metab 88 12 2003 5907 5913 (Pubitemid 38033071)
20. D. Chin, C. Shackleton, and V.K. Prasad Increased 5alpha-reductase and normal 11beta-hydroxysteroid dehydrogenase metabolism of C19 and C21 steroids in a young population with polycystic ovarian syndrome J Pediatr Endocrinol Metab 13 3 2000 253 259 (Pubitemid 30163749)
21. A. Rodin, H. Thakkar, N. Taylor, and R. Clayton Hyperandrogenism in polycystic ovary syndrome Evidence of dysregulation of 11 beta-hydroxysteroid dehydrogenase N Engl J Med 330 7 1994 460 465 (Pubitemid 24058934)
22. M.O. Goodarzi, N.A. Shah, H.J. Antoine, M. Pall, X. Guo, and R. Azziz Variants in the 5alpha-reductase type 1 and type 2 genes are associated with polycystic ovary syndrome and the severity of hirsutism in affected women J Clin Endocrinol Metab 91 10 2006 4085 4091 (Pubitemid 44536889)
23. M.O. Goodarzi Looking for polycystic ovary syndrome genes: rational and best strategy Semin Reprod Med 26 1 2008 5 13
24. R. Hatch, R.L. Rosenfield, M.H. Kim, and D. Tredway Hirsutism: implications, etiology, and management Am J Obstet Gynecol 140 7 1981 815 830 (Pubitemid 11046650)
25. R.S. Legro, V.D. Castracane, and R.P. Kauffman Detecting insulin resistance in polycystic ovary syndrome: purposes and pitfalls Obstet Gynecol Surv 59 2 2004 141 154 (Pubitemid 38140845)
26. J.E. Morley, P. Patrick, and H.M. Perry Evaluation of assays available to measure free testosterone Metab Clin Exp 51 5 2002 554 559 (Pubitemid 34516507)
27. D.A. Vassiliadi, T.M. Barber, and B.A. Hughes Increased 5 alpha-reductase activity and adrenocortical drive in women with polycystic ovary syndrome J Clin Endocrinol Metab 94 9 2009 3558 3566
28. P.M. Stewart, C.H. Shackleton, G.H. Beastall, and C.R. Edwards 5alpha-Reductase activity in polycystic ovary syndrome Lancet 335 8687 1990 431 433 (Pubitemid 20054649)
29. I.O. Oliveira, C. Lhullier, I.S. Brum, and P.M. Spritzer The 5alpha-reductase type 1, but not type 2, gene is expressed in anagen hairs plucked from the vertex area of the scalp of hirsute women and normal individuals Braz J Med Biol Res 36 10 2003 1447 1454 (Pubitemid 37322277)
30. G. Courchay, N. Boyera, B.A. Bernard, Y. Mahe, and Messenger RNA expression of steroidogenesis enzyme subtypes in the human pilosebaceous unit Skin Pharmacol 9 3 1996 169 176 (Pubitemid 26149686)
31. C. Gerst, M. Dalko, P. Pichaud, J.B. Galey, B. Buan, and B.A. Bernard Type-1 steroid 5 alpha-reductase is functionally active in the hair follicle as evidenced by new selective inhibitors of either type-1 or type-2 human steroid 5 alpha-reductase Exp Dermatol 11 1 2002 52 58 (Pubitemid 36934624)
32. S. Franks, M.I. McCarthy, and K. Hardy Development of polycystic ovary syndrome: involvement of genetic and environmental factors Int J Androl 29 1 2006 278 285 [discussion 286-90]